Sign in

CIK 0001740279 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

IN8BIO, INC.

Sign in to watch
Ticker
INAB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
825462585
Phone
(646) 600-6438
Business address
EMPIRE STATE BUILDING, 350 5TH AVENUE, SUITE 5330, NEW YORK, NY, 10118
Former names
Incysus Therapeutics, Inc.
  1. 4 Insider Changes in Ownership
  2. 4 Insider Changes in Ownership
  3. 4 Insider Changes in Ownership
  4. 4 Insider Changes in Ownership
  5. 4 Insider Changes in Ownership
  6. 4 Insider Changes in Ownership
  7. 4 Insider Changes in Ownership
  8. 8-K Event Material agreement · Regulation FD disclosure
  9. 424B4 Offering Prospectus
  10. POS EX Other Post-effective Amendment
  11. 10-Q Report Quarterly Report
  12. 8-K Event Results of operations
  13. EFFECT Other Notice of Effectiveness
  14. S-1/A Offering Registration Statement
  15. CORRESP Other Correspondence Between Filers and SEC Staff
  16. CORRESP Other Correspondence Between Filers and SEC Staff
  17. 8-K Event Results of operations
  18. S-1 Offering Registration Statement
  19. 8-K Event Other events
  20. UPLOAD Other SEC-generated Letter

Page 16 of 21 · 412 filings